
Background: Mulberry (Morus alba) leaf extracts containing 1-deoxynojirimycin (DNJ) may attenuate postprandial glycaemic responses through intestinal α-glucosidase inhibition. However, evidence regarding ready-to-drink pre-meal formulations remains limited. Objective: To evaluate postprandial glucose responses following a standardized high- 25 glycaemic breakfast consumed with or without a mulberry-based liquid shot (Suxero®). Methods: In this open-label, non-randomized, two-period observational crossover pilot study, 16 adults completed two test mornings separated by seven days. Participants consumed a standardized breakfast alone or preceded by a 60 mL shot containing mulberry leaf extract standardized to 5% DNJ, lemon peel extract and vitamin C. Interstitial glucose was assessed using continuous glucose monitoring at baseline and 30, 60, 120 and 180 minutes after meal initiation. Results: Mean peak glucose was lower following the shot than under the control condition (203.3 ± 57.6 vs 238.5 ± 70.3 mg/dL; mean paired difference −35.2 mg/dL, 95% CI −56.7 to −13.7; p = 0.003), corresponding to a 14.8% reduction in group mean peak glucose. Peak values were lower in 13 of 16 participants. The three-hour incremental area under the curve was 19.3% lower but did not reach statistical significance (p = 0.14). No adverse events were reported. Conclusion: Consumption of a DNJ-standardised mulberry-based shot before a high- glycaemic breakfast was associated with a statistically significant reduction in observed postprandial peak glucose in this small pilot study. The findings require confirmation in adequately powered, randomised, placebo-controlled trials.
Background and Objective: The Triglyceride-To-High-Density Lipoprotein Cholesterol (TG/HDL-C) ratio may help identify metabolic abnormalities. This study evaluated its association with insulin resistance and its discriminatory performance and optimal cutoff in young Mexican adults. Materials and Methods: This cross-sectional study included 346 university students aged 18–30 years from the University of Guadalajara. Insulin resistance was defined as a homeostatic model assessment of insulin resistance (HOMA-IR) value >2.5. Associations were assessed using correlation and linear regression analyses. Discriminatory performance and the optimal cutoff were evaluated using Receiver Operating Characteristic (ROC) analysis and the Youden index. Results: Participants had a mean age of 20.8 ± 2.0 years, and 73.7% were women. Overall, 23.1% met the criterion for insulin resistance. The TG/HDL-C ratio was higher in participants with insulin resistance than in those without it (2.35 ± 1.61 vs. 1.70 ± 1.00, p < 0.001) and was positively correlated with HOMA-IR (ρ = 0.246, p < 0.001). The area under the ROC curve was 0.635 (95% CI: 0.559–0.705). The optimal cutoff was 2.558, with 37.5% sensitivity and 86.8% specificity. In sex-stratified analyses, the AUC was 0.656 in women and 0.579 in men. Conclusion: The TG/HDL-C ratio showed a modest association with insulin resistance and limited discriminatory ability. The cutoff had low sensitivity despite relatively high specificity; external validation is needed before application in other populations.
Backgrounds: Anthropometric measurements play a vital role in clinical assessment, decision making and diagnosis. Methods: This is a cross-sectional, case-controlled, multicenter study. A purposeful sampling technique was used to recruit 50 newly diagnosed type 2 DM subjects within 3 weeks of their diagnosis. Also, apparently healthy 50 non-diabetic with no significant medical history were recruited as controls. Waist Circumference (WC) was measured and Waist to Height Ratio (WHtR) was calculated. Results: There were 32 males and 68 females, with Male: Female ratio of 1:2. A Multiple linear regression analysis model was not statistically significant, F (2,97) = 0.884, p = .416, with an R² of .018 and an adjusted R² of −.002. WC and WHtR jointly explained approximately 1.8% of the variance in glycated hemoglobin (HbA1c).The lowest mean of HbA1c was in the control group (5.4%), then total (general ) population group (6.9%) while the new onset type 2 DM patients group had the highest (8.3%).WHtR was not a significant independent predictor (B = 13.889, β = .393, p = .292, 95% CI: −12.125 to 39.903) of HbA1c.A Sudanese study also reported no significant correlation between WHtR and HbA1c. Conclusion: WC and WHtR decreases in size and number as we move from a cohort of new onset type 2 DM patient to the general population and then to a control group.
Type 2 diabetes is a chronic disease associated with serious adverse multisystem complications. Diet and lifestyle play a major role in its pathogenesis and management. Historically, various traditional remedies have been used to treat the disease. Over the past few decades, several pharmaceutical preparations have been developed to treat patients with diabetes. However, literature indicate that some of the diabetic patients may not be compliant with their recommended medications. On the other hand, there is increasing awareness and popularity in using natural products over synthetic drugs. In this synopsis of evidence, we have put together available information from both pre-clinical and clinical investigations to highlight potential anti-diabetic effects of some specific botanical by-products. Future studies may lead to the development of affordable, safe and effective products that can be used in the management of type 2 diabetes along with other evidence-based therapies.
The kidneys consist of countless glomeruli, which are clusters of capillaries responsible for filtering blood, allowing the urine formed to travel through the ureters to the bladder, from which it is expelled via the urethra. In the initial phases of diabetic nephropathy, the glomeruli experience enlargement attributed to early changes in hemodynamics and elevated pressure within them. This leads to impairment of the glomerular membrane, resulting in the leakage of albumin and additional proteins into the urine. The thickness of the glomerular membrane can reach up to three times its normal size, particularly in individuals exhibiting microalbuminuria. As the condition progresses, glomerular sclerosis takes place, demonstrated by a decline in kidney functionality. The early identification approach for nephropathy relies on detecting microalbumin in a sample of first-morning urine, while ongoing monitoring necessitates evaluating albumin in a 24-hour urine sample. Measuring serum creatinine serves as a solid gauge of kidney health. As blood pressure may be mildly elevated during the initial phases, conducting a 24-hour Holter blood pressure analysis is essential to ensure that pressure does not lower during the night, which can frequently indicate the onset of diabetic nephropathy.